The growing demand for plasma-derived medicines and increasing investments in blood collection infrastructure are driving steady growth in the Plasma Collection Market. Plasma collection plays a critical role in producing life-saving therapies, including immunoglobulins, albumin, clotting factors, and other plasma-derived biologics used to treat immune deficiencies, bleeding disorders, neurological diseases, and rare conditions. According to WiseGuyReports, the global plasma collection market is projected to grow from USD 5.74 billion in 2025 to USD 10.5 billion by 2035, registering a 6.2% CAGR during the forecast period. Rising prevalence of chronic diseases, increasing plasma donations, and technological advancements in automated plasmapheresis systems are supporting long-term market expansion.

North America currently dominates the market due to its extensive plasma donation network, advanced healthcare infrastructure, and strong presence of plasma fractionation companies. Meanwhile, Asia-Pacific is expected to witness the fastest growth as healthcare investments increase and awareness of plasma donation continues to improve. Manufacturers and collection centers are adopting automated plasma collection technologies, digital donor management systems, and enhanced screening protocols to improve operational efficiency and donor safety. As demand for plasma-derived therapeutics continues to rise worldwide, the plasma collection market is expected to maintain sustained growth over the coming decade.

FAQ

Q1. What is plasma collection?
Plasma collection is the process of obtaining blood plasma from donors using whole blood collection or plasmapheresis. The collected plasma is processed to manufacture therapies for immune disorders, bleeding conditions, and other serious diseases.

Q2. What is driving the plasma collection market?
The market is driven by increasing demand for plasma-derived medicines, rising prevalence of rare and chronic diseases, growing plasma donation programs, and advances in automated collection technologies.

Q3. Which region leads the plasma collection market?
North America currently holds the largest market share, while Asia-Pacific is expected to register the fastest growth due to expanding healthcare infrastructure, increasing plasma collection capacity, and rising demand for plasma-derived therapies.